Skip to content

Walking and Thinking - Brain Activity During Complex Walking in Aging and Parkinson's Disease

Walking and Thinking - Brain Activity During Complex Walking in Aging and Parkinson's Disease (Part of the ParkMOVE Trial)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05218213
Acronym
ParkMOVE
Enrollment
133
Registered
2022-02-01
Start date
2022-01-21
Completion date
2023-06-28
Last updated
2024-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Gait Disorders, Neurologic, Parkinson Disease

Keywords

functional near infrared spectrometry, gait, physical activity

Brief summary

Every-day life means being part of a complex environment and performing complex tasks that usually involve a combination of motor and cognitive skills. However, the process of aging or the sequelae of neurological diseases such as Parkinson's disease (PD) compromises motor-cognitive interaction necessary for an independent lifestyle. While motor-cognitive performance has been identified as an important goal for sustained health across different clinical populations, little is known about underlying brain function leading to these difficulties and how to best target these motor-cognitive difficulties in the context of rehabilitation and exercise interventions. The challenge of improving treatments of motor-cognitive difficulties (such as dual-tasking and navigation) is daunting, and an important step is arriving at a method that accurately portrays these impairments in an ecological valid state. The investigators aim therefore to explore brain function during complex walking in healthy and PD by investigating the effects of age and neurological disease on motor-cognitive performance and its neural correlates during three conditions of complex walking (dual-task walking, navigation and a combination of both) using non-invasive measures of brain activity (functional near infrared spectrometry, fNIRS) and advanced gait analysis in real time in young, older healthy adults and people with PD.

Interventions

OTHERNo intervention

Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions. 1. Dual-task walking with the auditory stroop task. 2. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right 3. Navigational and dual-task walking (condition 1 and 2 together)

Sponsors

Karolinska University Hospital
CollaboratorOTHER
Karolinska Institutet
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Healthy young: Inclusion criteria: -18 to 50 years

Exclusion criteria

* Disease or condition that affects cognition, gait or balance. * Severe hearing or visual impairments that affects participation in the assessments Healthy elderly: Inclusion criteria: * ≥60 years of age, * 23 or more on the Montreal Cognitive Assessment (MoCA)

Design outcomes

Primary

MeasureTime frameDescription
Functional near infrared spectrometry (fNIRS)During the test session during all three conditionsThe measurement of changes in concentration of HbO and HHb in the prefrontal cortex will be assessed using a NIRSPORT 2 (NIRx Medizintechnik, Berlin, Germany) device
Gait performance during all conditionsDuring the test session during all three conditionsGait variables such as stride time and/or velocity will be analyzed with the APDM mobility system.
Dual-task performance-reaction timeDuring the test session during dual task conditionsCognitive performance of the dual task will be assessed as errors in the response to the Auditory stroop task.

Secondary

MeasureTime frameDescription
Cognitive function - Episodic memoryDuring the test session, takes about 30 minutesEpisodic memory will be assessed with the Ray Auditory Verbal Learning Test (RAVLT).
Cognitive function - Inhibition & task-set switchingDuring the test session, takes about 5 minutesInhibition & task-set switching with the The Color-Word Interference Test (CWIT) from D-KEFS (Delis-Kaplan Executive Function System)
Self-reported level of physical activityThrough study completion, an average of 1 yearAssessed with the Frändin-Grimby Scale (score 1-6, higher score=better)
Physical activity level and intensityFor one week after the test sessionAssessed with accelerometers (Actigraph GT3X+)
Motor function/disease severityDuring the test sessionAssessed with the movement Disorders Society- Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Higher scores = worse/more symptoms
Cognitive function- composite scoreDuring the test session, takes about 50 minutesThe cognitive test battery comprised the following tests: The Color-Word Interference Test (CWIT), Verbal Fluency, Trail Making Test (TMT) and Ray Auditory Verbal Learning Test (RAVLT). Cognitive function will be assessed as a composite measure of these test together.
Anxiety and depressionWill be answered before the test session in the patients home or during the test sessionAssessed with Hospital Anxiety and Depression Scale (HADS), 0-24 on the depression and anxiety part respectively. Lower score=better
Walking abilityWill be answered before the test session in the patients home or at the test sessionSelf assessed walking ability with the WALK-12G
Dual-task performance -errorsDuring the test session during dual task conditionsCognitive performance of the dual task will be assessed as the reaction time to respond during Auditory stroop
DisabilityWill be answered before the test session in the patients home or during the test sessionWHO Disability Assessment Schedule (WHODAS) version 2.0, 12 self-assessed questions (12 to 60) more points=worse
Balance performanceDuring the test sessionAssessed with the Mini-BESTest (Balance Evaluation Systems test), 0-28p,
Cognitive function - verbal fluencyDuring the test session, takes about 12 minutesVerbal function, initiation & task-set switching with the Verbal Fluency test from D-KEFS (Delis-Kaplan Executive Function System)
Cognitive function - Attention and psychomotor processing speedDuring the test session, takes about 3 minutesAttention and psychomotor processing speed will be assessed with the Trail Making Test (TMT) from D-KEFS (Delis-Kaplan Executive Function System)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026